TBRA Insider Trading Activity and SEC Form 4 Filings
TBRA insider trading summary
No open-market insider purchases or sales of Tobira Therapeutics, Inc. (TBRA) have been reported on SEC Form 4 in the past 12 months.
Latest TBRA insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 31, 2016 | Pentwater Capital Management LP | Insider | Buy | $417K (10,000 @ $41.71) |
| Oct 31, 2016 | Pentwater Capital Management LP | Insider | Buy | $211K (5,000 @ $42.10) |
| Oct 18, 2016 | Pentwater Capital Management LP | Insider | Buy | $332K (8,300 @ $40.04) |
| Oct 17, 2016 | Pentwater Capital Management LP | Insider | Buy | $172K (4,300 @ $39.89) |
| Oct 17, 2016 | Pentwater Capital Management LP | Insider | Buy | $1.1M (27,400 @ $40.10) |
| Oct 4, 2016 | Pentwater Capital Management LP | Insider | Buy | $178K (4,481 @ $39.83) |
| Sep 29, 2016 | Pentwater Capital Management LP | Insider | Buy | $257K (6,500 @ $39.49) |
| Sep 29, 2016 | Pentwater Capital Management LP | Insider | Buy | $356K (9,019 @ $39.49) |
| Sep 26, 2016 | Pentwater Capital Management LP | Insider | Buy | $23K (600 @ $39.01) |
| Sep 26, 2016 | Pentwater Capital Management LP | Insider | Buy | $1.9M (49,400 @ $39.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.